Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ABOBOTULINUMTOXINA vs ACALABRUTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ABOBOTULINUMTOXINA vs ACALABRUTINIB: Safety Overview

Metric ABOBOTULINUMTOXINA ACALABRUTINIB
Total FAERS Reports 5,789 9,688
Deaths Reported 109 2,239
Death Rate 1.9% 23.1%
Hospitalizations 406 2,441
Average Patient Age 46.6 yrs 73.2 yrs
% Female Patients 87.3% 36.8%
FDA Approval Date N/A Aug 3, 2022
Manufacturer N/A AstraZeneca Pharmaceuticals LP
Route N/A ORAL
Marketing Status Prescription Prescription